FIELD: medicine, psychiatry.
SUBSTANCE: additionally to prescribing atypical neuroleptic preparations of antinegative impact it is necessary prescribe the course of electroconvulsive therapy: 2 seances weekly, the course consists of 8 seances. The procedure should be conducted by applying deprivane anesthesia followed by introducing myorelaxant (listhenon) and ligature control for convulsive activity. Electrodes should be put bilaterally, the impact comes at voltage of 80-120 V for 0.3-0.8 sec. The innovation enables to decrease side effects and complications due to matching special mode that combines atypical neuroleptics and electroconvulsive therapy.
EFFECT: higher efficiency of therapy.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
APPLICATION OF TIZANIDINE AS DRUG-INDUCED PARKINSONISM CORRECTOR | 2008 |
|
RU2393860C2 |
METHOD FOR TREATING THE CASES OF SCHIZOPHRENIA | 2000 |
|
RU2164799C1 |
METHOD FOR EVALUATING COMBINED SCHIZOPHRENIA TREATMENT BASED ON ATYPICAL ANTIPSYCHOTIC DRUGS AND RATIONS AND ELECTROCONVULSIVE SHOCK THERAPY | 2004 |
|
RU2256181C1 |
METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
METHOD OF TREATING SCHIZOPHRENIA | 2011 |
|
RU2484836C2 |
METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
METHOD FOR CARRYING OUT COMBINED REDUCTION OF SCHIZO-AFFECTIVE SYNDROMES OF PSYCHOTIC AND SUBPSYCHOTIC LEVEL IN DAY CARE HOSPITAL | 2003 |
|
RU2249456C1 |
USE OF METHYL ETHER OF N-CAPROYL-L-PROLYL-L-TYROSINE (DILEPT) AS AGENT WITH PSYCHOSTIMULANT ACTIVITY | 2015 |
|
RU2593886C1 |
Authors
Dates
2005-12-20—Published
2004-03-30—Filed